How to Buy Immuneering Stock

Immuneering Corp

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates.

Immuneering stock last closed at $1.38, up 8.66% from the previous day, and has decreased 19.77% in one year. It has overperformed other stocks in the Biotechnology industry by 0.58 percentage points. Immuneering stock is currently +38% from its 52-week low of $1.00, and -63.97% from its 52-week high of $3.83.

At the moment, there are 35.89M shares of IMRX outstanding. The market value of IMRX is $49.52M. In the last 24 hours, 120,646 IMRX shares were traded.

How to Buy Immuneering Stock

Not sure how to invest in Immuneering stock? Here's how.

  1. Decide where to buy Immuneering stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Immuneering stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Select your payment method and add your info.
  4. Research Immuneering stock: The Immuneering ticker symbol is IMRX. Is Immuneering stock a good investment? Should you buy shares of IMRX? How do IMRX's underlying business fundamentals look? Do top analysts think Immuneering is a good buy? Why has IMRX's stock price moved recently? (Hint: Our stock market research website can help you figure out if IMRX is a good stock to buy).
  5. Place your IMRX trade: Decide if you will purchase IMRX shares at the current market price or use a limit order to purchase IMRX shares at a particular price.
  6. Get the latest news on your investment in IMRX: Create a watchlist to keep tabs on your position in Immuneering shares.

Step 1: Decide where to buy Immuneering stock

You will need an online brokerage account to access the NASDAQ market and buy IMRX stock.

A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global financial markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've chosen your brokerage, you need to fill out some personal information so you can buy IMRX today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open your new brokerage account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you have opened your account on the best stock buying app, your next step is to transfer the money for your investment:

Watch the walkthrough below if you need help depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Immuneering stock

Once you have chosen the best place to buy Immuneering stock, it's important to evaluate their stock before you buy, so you can wrap your head around the risk and upside.

Immuneering quick stats

IMRX Price
$1.38
1w %
6.15%
1y %
-19.77%
5y %
N/A
P/E
-0.68x
P/B
1.2x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$61.04M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$49.52M
Next Earnings
N/A
Next Dividend
N/A

IMRX Overview

WallStreetZen was created to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on IMRX's stock page.

Is IMRX stock undervalued or overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge IMRX's true value.

Using relative valuations ratios:

  • IMRX may be undervalued based on its P/B ratio of 1.2x, relative to Biotechnology industry P/B ratio of 4.04x

You can do more valuation research on IMRX's stock here.

IMRX Financial Health

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the IMRX balance sheet.
  • Total IMRX debt is lower than 5 years ago, relative to shareholder equity.
  • IMRX has a low debt to equity ratio of 0.27.
  • There are more short-term assets than short-term liabilities on the IMRX balance sheet.

Negative Health Checks:

  • IMRX has cash burn of 55084446. It does not have enough cash and short-term investments to cover this.
  • IMRX has $36.14M in cash and short term investments. This is not enough to cover its annual cash burn of $55.08M.

Is it a good time to buy Immuneering stock, according to analysts?

Out of 2 sell side analysts who give recommendations on IMRX, the consensus analyst rating on Immuneering is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Immuneering stock forecast page.

IMRX Technicals

SMA10
1.29
SMA20
1.44
SMA50
1.58
SMA100
1.81
SMA200
1.76
MACD
-0.1
MACD Signal
-0.09
MACD Histogram
0
RSI
44.74
Stochastic %K
33.22
Stochastic %D
28.66
StochRSI %K
56.07
StochRSI %D
40.05

How are IMRX Revenues/Earnings doing?

Last year, IMRX revenue was $0.00. Over the last 5 year, IMRX's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 44.31%.

You can research IMRX's earnings and revenue performance here.

What are IMRX executives and large shareholders up to?

In the last 12 months, executives and large shareholders at IMRX have bought more shares than they have sold.

Mallory Morales, Chief Accounting Officer of IMRX, was the latest IMRX insider to buy. They bought $7,235.33 worth of IMRX shares on Sep 15, 2024.

Get more info about who owns IMRX shares here.

Can I get consistent income from IMRX stock?

No, Immuneering doesn't provide an income stream by paying out dividends.

What do other traders have to say about IMRX?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your IMRX trade

There are two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a particular dollar amount, use a limit order.

Press the Open Trade button and your broker will execute the order.

If you require additional help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest news on your investment in IMRX

Now that you own some shares in IMRX, you'll want to stay up-to-date on your investment.

Put IMRX on a watchlist to track the latest developments regarding your IMRX stock.

IMRX Feed

How to Buy Stock in Immuneering

To reiterate, here are the 6 steps to buy stock in Immuneering:

  1. Decide where to buy Immuneering stock
  2. Create your brokerage account
  3. Put funds into your investment account
  4. Research Immuneering stock
  5. Place your IMRX trade
  6. Get the latest news on your investment in IMRX

If you are looking for a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep track of your investment in Immuneering, create a watchlist today.

NASDAQ: IMRX
$1.38+0.11 (+8.66%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: IMRX
$1.38+0.11 (+8.66%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Immuneering share?

As of Apr 21, 2025, it costs $1.38 to buy one share of Immuneering stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.69, you can buy 0.5 shares of IMRX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Immuneering stock?

According to 2 Wall Street analysts who monitor Immuneering, their consensus recommendation is to buy Immuneering stock.

What is the best way to buy Immuneering stock?

One way to place an order for Immuneering stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.